Diagnosis of osteoporosis in statin-treated patients is dose-dependent

OBJECTIVE: Whether HMG-CoA-reductase inhibition, the main mechanism of statins, plays a role in the pathogenesis of osteoporosis, is not entirely known so far. Consequently, this study was set out to investigate the relationship of different kinds and dosages of statins with osteoporosis, hypothesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Leutner, Michael, Matzhold, Caspar, Bellach, Luise, Deischinger, Carola, Harreiter, Jürgen, Thurner, Stefan, Klimek, Peter, Kautzky-Willer, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Osteoporosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900255/
https://www.ncbi.nlm.nih.gov/pubmed/31558481
http://dx.doi.org/10.1136/annrheumdis-2019-215714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900255/
https://www.ncbi.nlm.nih.gov/pubmed/31558481
http://dx.doi.org/10.1136/annrheumdis-2019-215714

Ejemplares similares